Cargando…

Pathogenesis and potential therapeutic application of stem cells transplantation in Huntington’s disease

Huntington's disease (HD) is a progressive neurodegenerative disorder which is caused due to repetitive CAG or glutamine expression along the coding region of the Huntington gene. This disease results in certain movement abnormalities, affective disturbances, dementia and cognitive impairments....

Descripción completa

Detalles Bibliográficos
Autores principales:	Saha, Sudeepto, Dey, Manami Jayati, Promon, Salman Khan, Araf, Yusha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society for Regenerative Medicine 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513215/ https://www.ncbi.nlm.nih.gov/pubmed/36196447 http://dx.doi.org/10.1016/j.reth.2022.09.001

Ejemplares similares

Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury
por: Akter, Fariya, et al.
Publicado: (2021)

The promising rise of bioprinting in revolutionalizing medical science: Advances and possibilities
por: Jamee, Radia, et al.
Publicado: (2021)

3D Bioprinting for Regenerating COVID-19-Mediated Irreversibly Damaged Lung Tissue
por: Akter, Fariya, et al.
Publicado: (2022)

Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
por: Jurcau, Anamaria, et al.
Publicado: (2022)

Microglial Activation in the Pathogenesis of Huntington’s Disease
por: Yang, Hui-Ming, et al.
Publicado: (2017)

From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research
por: Jiang, Andrew, et al.
Publicado: (2023)

Insights from a computational analysis of the SARS‐CoV‐2 Omicron variant: Host–pathogen interaction, pathogenicity, and possible drug therapeutics
por: Parvez, Md Sorwer Alam, et al.
Publicado: (2022)

Multiple pathways contribute to the pathogenesis of Huntington disease
por: Li, Shihua, et al.
Publicado: (2006)

Biological Aging and the Cellular Pathogenesis of Huntington’s Disease
por: Machiela, Emily, et al.
Publicado: (2020)

Huntington’s Disease Pathogenesis: Two Sequential Components
por: Hong, Eun Pyo, et al.
Publicado: (2021)

Pathogenesis of Huntington’s Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies
por: Irfan, Zainab, et al.
Publicado: (2022)

Corticosteroids for COVID-19: worth it or not?
por: Akter, Fariya, et al.
Publicado: (2021)

In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases
por: Chowdhury, Neeladri, et al.
Publicado: (2017)

Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease
por: Labanca, Fabiana, et al.
Publicado: (2021)

Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics
por: Mees, Isaline, et al.
Publicado: (2023)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Therapeutic Advances for Huntington’s Disease
por: Kumar, Ashok, et al.
Publicado: (2020)

Potential Effects of the COVID-19 Pandemic on Future Birth Rate
por: Ullah, Md. Asad, et al.
Publicado: (2020)

Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
por: Chang, Renbao, et al.
Publicado: (2015)

Gut Bacteria Regulate the Pathogenesis of Huntington’s Disease in Drosophila Model
por: Chongtham, Anjalika, et al.
Publicado: (2022)

Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans
por: Voisine, Cindy, et al.
Publicado: (2007)

Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease
por: Skogen, Michael, et al.
Publicado: (2006)

Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease
por: Olson, Scott D., et al.
Publicado: (2011)

An In-Silico Identification of Potential Flavonoids against Kidney Fibrosis Targeting TGFβR-1
por: Rahman, MD. Hasanur, et al.
Publicado: (2022)

Therapeutic Advances in the Management of Huntington’s Disease
por: Abdulrahman, Ganiy Opeyemi
Publicado: (2011)

Bioethanol production using vegetable peels medium and the effective role of cellulolytic bacterial (Bacillus subtilis) pre-treatment
por: Promon, Salman Khan, et al.
Publicado: (2018)

Engineering a novel subunit vaccine against SARS-CoV-2 by exploring immunoinformatics approach
por: Sarkar, Bishajit, et al.
Publicado: (2020)

SARS-CoV-2: a new dimension to our understanding of coronaviruses
por: Araf, Yusha, et al.
Publicado: (2020)

HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington’s disease pathogenesis
por: Xu, Shiyu, et al.
Publicado: (2022)

The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease
por: Tung, Chih-Wei, et al.
Publicado: (2021)

Corrigendum: Gut bacteria regulate the pathogenesis of Huntington's disease in Drosophila model
por: Chongtham, Anjalika, et al.
Publicado: (2022)

Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease
por: Miguez, Andrés, et al.
Publicado: (2023)

Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington’s Disease
por: Mazarei, Gelareh, et al.
Publicado: (2015)

3244 The Autonomic Nervous System as a Potential Therapeutic Target in Huntington Disease
por: Schultz, Jordan L, et al.
Publicado: (2019)

Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice
por: Im, Wooseok, et al.
Publicado: (2010)

Transplantation of Induced Pluripotent Stem Cells Improves Functional Recovery in Huntington's Disease Rat Model
por: Mu, Shuhua, et al.
Publicado: (2014)

Crescentic Glomerulonephritis: Pathogenesis and Therapeutic Potential of Human Amniotic Stem Cells
por: Al Mushafi, Ahmed, et al.
Publicado: (2021)

Prospective selected biomarkers in COVID-19 diagnosis and treatment
por: Tabassum, Tahani, et al.
Publicado: (2021)

Management of asthma patients during the COVID-19 pandemic: pathophysiological considerations to address the challenges
por: Tabassum, Tahani, et al.
Publicado: (2022)

MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington's Disease Pathogenesis
por: Hoss, Andrew G., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rrf6o113jdqn7n0v77iiedflkc